10-Q Filing

GLOBAL MEDICAL REIT INC. CIK: 1533615 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001078782-13-000118`
Period End Date	20121130
Filing Date	20130116
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	scoo-20121130.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 31 Income Statement 13 Cash Flow Statement 40

Balance Sheet 31 line items

Line Item	Tag	Value	Unit	Period
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$47.29K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.19K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$47.42K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.50M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	8.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$11.19K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$12.31K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	8.00M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	5.50M	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$7.50K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$9.00K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$380.00	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$380.00	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$7.88K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$9.38K	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001 8,000,000 and 5,500,000 share issued and outstanding	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001 8,000,000 and 5,500,000 share issued and outstanding	`CommonStockValue`	$5.50K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.50K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$72.00K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-78.19K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-50.57K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$1.81K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$4.43K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$11.19K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$12.31K	USD	Point-in-time

Income Statement 13 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$78.19K	USD	7 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.63K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$27.62K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$27.62K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$7.63K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$78.19K	USD	7 Qtrs
Net Loss	`NetIncomeLoss`	$-27.62K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-7.63K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-78.19K	USD	7 Qtrs
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	7.31M	shares	1 Quarter
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	5.50M	shares	1 Quarter

Cash Flow Statement 40 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-7.63K	USD	1 Quarter
Net loss	`ProfitLoss`	$-78.19K	USD	7 Qtrs
Net loss	`ProfitLoss`	$-27.62K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$7.50K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	7 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.50K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	-	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$9.00K	USD	7 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.12K	USD	1 Quarter
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-69.19K	USD	7 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-135.00	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$25.00K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$80.00K	USD	7 Qtrs
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	-	USD	1 Quarter
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	$380.00	USD	7 Qtrs
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	-	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$25.00K	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$80.38K	USD	7 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-135.00	USD	1 Quarter
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.12K	USD	1 Quarter
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$11.19K	USD	7 Qtrs
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.29K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.19K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.42K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.29K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.19K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.42K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	1 Quarter
Interest paid	`InterestPaid`	-	USD	1 Quarter
Interest paid	`InterestPaid`	-	USD	7 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	7 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.